Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Altus Power Announces Innovative Tax Partnership, Maximizing Market Efficiency
-
Hydrafacial Launches New Hydralock HA Booster with Clinically Proven Results
-
NetSPI Achieves Platform Consolidation Milestone, Empowers Customers to Implement Effective CTEM Programs
-
Omnia Exterior Solutions Extends its Midwest Footprint with New Partner, Central Roofing
-
ManTech Wins $63 Million Contract With Naval Surface Warfare Center Port Hueneme Division
-
TJC Closes Second Continuation Fund of $2.1 Billion Led by AlpInvest
-
Plexium Announces Appointment of Jorge F. DiMartino, M.D., Ph.D. as Chief Medical Officer
-
Global Telecom Set to Launch Advanced 5G Devices and CPE Lineup at MWC
-
Stryker completes acquisition of Vertos Medical, Inc., expanding interventional pain management solutions
-
LL Flooring Completes Sale to F9 Investments
-
Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in its Deltacel-01 Clinical Trial
-
Most IT Pros Embrace AI as a Cyberdefense Ally, GetApp's Data Security Survey Reveals
-
USPTO Approves edatanetworks Patent for Automated Cause Marketing
-
LMP Capital and Income Fund Inc. (SCD or “the Fund”; CUSIP: 50208A102) Announces Notification of Sources of Distributions
-
ILiAD Biotechnologies to Participate in Upcoming Investor Conferences
-
SchoolMint Announces Major Investment in Hero Platform to Better Protect and Serve Customers
-
GeneCentric Therapeutics Announces Publication of Clinicogenomic Results from GARNER Study in High-Risk Non-Muscle Invasive Bladder Cancer
-
Pramata and Deloitte Help Clients Apply Generative AI to Contract Analytics
-
Manulife Investment Management Returns to Cboe Canada for Launch of Three New ETF Series
-
Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
-
Papillon Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for PPL-002 for the Treatment of Danon Disease
-
Business Owners and Public Relations Leaders Celebrate National Entrepreneur Month 2024: Empowering Careers and Communities
-
Stax Acquires BlockChyp, Adding Payment Gateway and Expanding End-to-End Capabilities
-
Industrial Logistics Properties Trust Third Quarter 2024 Conference Call Scheduled for Wednesday, October 30th
-
AtriCure Receives CE-Mark for the EnCompass® Clamp
-
OceanSound Partners Closes $1.49 Billion Fund II
-
HilltopSecurities Launches 4th Annual Hilltop Hunt
-
Food and Dining Industry Visionaries Richard Schenkel and Joe Cuticelli Launch Restaura, a Breakthrough Culinary Services Company
-
For October’s Economic Education Month, CEE Brings Financial Content, Events, Advocacy to Students and Teachers Across America
-
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS ENCOURAGES MEMBERS TO DISCUSS COLORECTAL CANCER SCREENING WITH THEIR DOCTOR
-
Abacus Life Appoints Robert F. Phillips as Senior Vice President, Investor Relations and Corporate Affairs
-
Atlantic Union Bankshares Corporation To Release Third Quarter 2024 Financial Results
-
Cerabyte to Present on AI-Driven Paradigm Shifts in Data Storage at Yotta 2024
-
Boca West Children's Foundation Celebrates 15th Anniversary with Gala Featuring Wynonna Judd
-
Catalogic Software Unveils Powerful New Features for Enhanced Data Recovery in DPX
-
Trilliant Health Releases 2024 Trends Shaping the Health Economy Report With 130+ Data Stories About the U.S. Healthcare System
-
Colossal Launches The Colossal Foundation
-
Siren Marine Introduces Siren 3
-
GALDERMA AND NATIONAL BREAST CANCER FOUNDATION COMMEMORATE TEN YEARS OF A BEAUTIFUL PARTNERSHIP
-
Luxa Biotechnology LLC Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer
-
TestRail Releases Landmark Report on AI’s Role in Quality Assurance
-
Applebee’s® Reveals Next Play in NFL Partnership with Applebee’s Pick 6 Mondays – Free Boneless Wings
-
Barinthus Bio Completes Enrollment for Phase 2b HBV003 Clinical Trial in Chronic Hepatitis B and Phase 1 PCA001 Clinical Trial in Prostate Cancer
-
Golden Matrix Group’s Division Meridianbet Expands Sports Wagering Product Suite
-
Mr. Kong, Nano Labs’ Chairman and CEO, Increased His Shareholding in the Company
-
Infinite Reality To Secure Majority Stake in Super League with Proposed Capital Commitment and Asset Transfer
-
New LRAD Systems to Enhance Security at Hoover Dam
-
Star Group, L.P. Announces New Credit Facility
-
Lead Real Estate Co., Ltd Announces Cash Dividend Payable Sept. 30, 2024
-
NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
